Ixabepilone + Carboplatin Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cynthia R Osborne, MD
US Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Arizona Oncology Associates, Pc - Nahoa
Sedona, Arizona, United States
- Arizona Oncology Associates, Pc - Hope
Tucson, Arizona, United States
- Southwest Cancer Care
Murrieta, California, United States
- Rocky Mountain Cancer Centers
Denver, Colorado, United States
- Florida Cancer Institute - New Hope
Hudson, Florida, United States
- Melbourne Internal Medicine Associates
Melbourne, Florida, United States
- Florida Institute of Research, Medicine & Surgery
Ocoee, Florida, United States
- Cancer Care & Hematology Specialists of Chicagoland
Niles, Illinois, United States
- Central Indiana Cancer Centers
Carmel, Indiana, United States
- Alliance Hematology Oncology, P.A.
Westminster, Maryland, United States
- Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States
- Maryland Oncology Hematology, Pa the Medical Pavillion at Howard County
Columbia, Missouri, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- Kansas City Cancer Center, Llc
Kansas City, Missouri, United States
- St. Joseph Oncology, Inc.
Saint Joseph, Missouri, United States
- Comprehensive Cancer Care Centers of Nevada
Henderson, Nevada, United States
- Hematology-Oncology Associates of Northern Nj, Pa Carol G. Simon Cancer Center
Morristown, New Jersey, United States
- Ruth Oratz Md
New York, New York, United States
- Interlakes Oncology & Hematology, P.C
Rochester, New York, United States
- Raleigh Hematology Oncology Associates
Raleigh, North Carolina, United States
- Dayton Oncology & Hematology, P.A. Greater Dayton Cancer Center
Kettering, Ohio, United States
- Northwest Cancer Specialists, Pc
Portland, Oregon, United States
- Medical Oncology Associates of Wyoming Valley, Pc
Kingston, Pennsylvania, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Texas Oncology - Abilene
Abilene, Texas, United States
- Texas Oncology - Amarillo
Amarillo, Texas, United States
- Texas Oncology - Austin Midtown
Austin, Texas, United States
- Texas Oncology - Bedford
Bedford, Texas, United States
- Texas Oncology
Dallas, Texas, United States
- Texas Oncology Medical City Dallas
Dallas, Texas, United States
- Texas Oncology-Dallas Presbyterian Hospital
Dallas, Texas, United States
- Texas Oncology-Methodist Charlton Cancer Center
Dallas, Texas, United States
- Texas Oncology- Denton South
Denton, Texas, United States
- Texas Oncology-Fort Worth 12 Ave
Fort Worth, Texas, United States
- Texas Oncology-Memorial City
Houston, Texas, United States
- Texas Oncology- Lewisville
Lewisville, Texas, United States
- Texas Oncology-Longview Cancer Center
Longview, Texas, United States
- Texas Oncology-Mcallen South Second Street
McAllen, Texas, United States
- Texas Oncology-Mesquite
Mesquite, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 7 Dec 2016
- Registered enrollment
- 103
- Registry id
- NCT01075100
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.